Site Sponsors
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions
Add Company

Eiffel Technologies Ltd

3 Innovation Road
North Ryde
New South Wales, 2113
Australia
PH: +61 (2) 9805 0022
Email: info@eiffeltechnologies.com.au
Visit Eiffel Technologies Ltd Website or Request Quote for Further Information

Company Background

Australian company, Eiffel Technologies Ltd utilises supercritical fluid (SCF) technologies to re-engineer pharmaceuticals and proteins to improve their bioavailability and effectiveness.

These technologies can be used to produce uniform, nano-scale particles with a very narrow size distribution, which have the potential to be delivered in more convenient and effective dose forms, such as reengineering an intravenous drug for delivery via inhaler.

SCF technology is well placed to enable the development of line extension products with superior performance to protect market share once patent life of branded pharmaceuticals expires.

Eiffel sponsors continuing research in pharmaceutical processing at its Pharmaceutical Re-engineering Facility at the University of NSW. Eiffel has signed eleven agreements since 2000, including those with Profile Therapeutics, Sheffield Pharmaceuticals, Amarin Corp, Oriel Therapeutics, Battellepharma and Meridica.

Services

Nano-biotechnology, Therapeutic Agents, Drug Delivery, Supercritical Fluid, Nanoparticles.

Sales Contact

Ms Christine Cussen

Ask A Question

Do you have a question you'd like to ask this Supplier?

Leave your feedback
Submit